|
AU3642795A
(en)
|
1994-09-27 |
1996-04-19 |
Merck & Co., Inc. |
Endothelin receptor antagonists for the treatment of emesis
|
|
US5939431A
(en)
*
|
1996-06-20 |
1999-08-17 |
Schering Corporation |
Naphthyridines which affect IL-4 and G-CSF
|
|
TW520362B
(en)
|
1996-12-05 |
2003-02-11 |
Amgen Inc |
Substituted pyrimidine compounds and pharmaceutical composition comprising same
|
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
WO2004078163A2
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
WO2003087044A2
(en)
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
|
AU2003286876A1
(en)
|
2002-11-01 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
US20040204422A1
(en)
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
SE0301654D0
(sv)
|
2003-06-05 |
2003-06-05 |
Astrazeneca Ab |
Novel compounds
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
EP1679309A4
(en)
|
2003-10-24 |
2007-03-28 |
Ono Pharmaceutical Co |
ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
MXPA06012130A
(es)
|
2004-04-20 |
2007-01-31 |
Transtech Pharma Inc |
Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina.
|
|
FR2874011B1
(fr)
|
2004-08-03 |
2007-06-15 |
Sanofi Synthelabo |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
WO2006020830A2
(en)
|
2004-08-12 |
2006-02-23 |
Amgen Inc. |
Bisaryl-sulfonamides
|
|
CN101035762B
(zh)
|
2004-10-04 |
2010-09-29 |
霍夫曼-拉罗奇有限公司 |
用于糖尿病的作为11-β抑制剂的烷基(alkil)-吡啶类
|
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
|
CA2620179C
(en)
|
2005-08-16 |
2013-10-29 |
Icagen, Inc. |
Inhibitors of voltage-gated sodium channels
|
|
WO2007023114A1
(en)
|
2005-08-25 |
2007-03-01 |
F. Hoffmann-La Roche Ag |
P38 map kinase inhibitors and methods for using the same
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
US20090076009A1
(en)
|
2006-05-03 |
2009-03-19 |
Arnould Jean-Claude Retired |
Thiazole derivatives and their use as anti-tumour agents
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2008008375A2
(en)
|
2006-07-14 |
2008-01-17 |
Chemocentryx, Inc. |
Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of inflammation
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
DK2420494T3
(en)
|
2006-08-16 |
2015-01-12 |
J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone |
Use of thiadiazole compounds as inhibitors of kynurenine 3-monooxygenase
|
|
JP2010502675A
(ja)
|
2006-09-08 |
2010-01-28 |
ノバルティス アクチエンゲゼルシャフト |
リンパ球相互作用が介在する疾患または障害を処置するために有用なｎ−ビアリール（ヘテロ）アリールスルホンアミド誘導体
|
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
|
AU2008294410B2
(en)
|
2007-04-11 |
2012-09-06 |
Canbas Co., Ltd. |
Compounds with anti-cancer activity
|
|
WO2008157500A1
(en)
|
2007-06-17 |
2008-12-24 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
EP2211615A4
(en)
|
2007-10-22 |
2010-10-13 |
Glaxosmithkline Llc |
PYRIDOSULFONAMIDE DERIVATIVES AS PI3 KINASE INHIBITORS
|
|
CA2714232A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
|
CA2726158A1
(en)
|
2008-06-11 |
2009-12-17 |
Dana Farber Cancer Institute |
Compounds and compositions useful for the treatment of malaria
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
|
WO2010123822A1
(en)
|
2009-04-20 |
2010-10-28 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
|
|
EP2253617A1
(de)
|
2009-05-20 |
2010-11-24 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
|
ES2626601T3
(es)
|
2010-06-28 |
2017-07-25 |
Bayer Intellectual Property Gmbh |
Compuestos heterocíclicos como pesticidas
|
|
WO2012004293A2
(de)
|
2010-07-08 |
2012-01-12 |
Bayer Cropscience Ag |
Insektizide und fungizide wirkstoffkombinationen
|
|
JP2014500303A
(ja)
|
2010-12-22 |
2014-01-09 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としての置換ピリジン
|
|
US9295676B2
(en)
|
2011-03-17 |
2016-03-29 |
The Trustees Of The University Of Pennsylvania |
Mutation mimicking compounds that bind to the kinase domain of EGFR
|
|
US9056867B2
(en)
|
2011-09-16 |
2015-06-16 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
|
EP2822931B1
(en)
*
|
2012-03-09 |
2017-05-03 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
|
CA2881357C
(en)
|
2012-08-21 |
2020-12-08 |
Peter Maccallum Cancer Institute |
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
US9771327B2
(en)
|
2013-03-13 |
2017-09-26 |
Flatley Discovery Lab, Llc |
Compounds and methods for the treatment of cystic fibrosis
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
AU2014372639A1
(en)
|
2013-12-23 |
2016-06-09 |
Norgine B.V. |
Benzene sulfonamides as CCR9 inhibitors
|
|
US9745292B2
(en)
|
2014-03-13 |
2017-08-29 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing CFTR activity
|
|
SG10201913603QA
(en)
|
2014-10-06 |
2020-02-27 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN104844566B
(zh)
|
2014-12-12 |
2018-05-18 |
合肥中科普瑞昇生物医药科技有限公司 |
一种新型结构的激酶抑制剂
|
|
RU2017146661A
(ru)
|
2015-06-02 |
2019-07-15 |
Эббви С.А.Р.Л. |
Замещенные пиридины и способ их применения
|
|
US9981945B2
(en)
|
2015-10-07 |
2018-05-29 |
NuBridge BioSciences |
Pyrimidine derivatives as CFTR modulators
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3436446B1
(en)
|
2016-03-31 |
2023-06-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
TW201811766A
(zh)
*
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|